Free Trial

Warby Parker (WRBY) Financials

Warby Parker logo
$28.75 +0.26 (+0.91%)
As of 02:32 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Warby Parker

Annual Income Statements for Warby Parker

This table shows Warby Parker's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-58 -56 -157 -110 -63 -20 1.64
Consolidated Net Income / (Loss)
0.00 -56 -144 -110 -63 -20 1.64
Net Income / (Loss) Continuing Operations
0.00 -56 -144 -110 -63 -20 1.64
Total Pre-Tax Income
0.28 -56 -144 -110 -63 -20 3.04
Total Operating Income
-1.66 -56 -144 -111 -72 -30 -5.34
Total Gross Profit
223 232 318 341 365 427 471
Total Revenue
370 394 541 598 670 771 872
Operating Revenue
370 394 541 598 670 771 872
Total Cost of Revenue
147 162 223 257 305 344 401
Operating Cost of Revenue
147 162 223 257 305 344 401
Total Operating Expenses
225 288 461 452 437 457 476
Selling, General & Admin Expense
225 288 461 452 437 457 476
Total Other Income / (Expense), net
1.94 -0.10 -0.35 1.31 9.23 11 8.38
Other Income / (Expense), net
1.94 -0.10 -0.35 1.31 9.23 11 8.38
Income Tax Expense
0.28 0.19 0.26 0.50 0.43 0.88 1.40
Basic Earnings per Share
($1.10) ($1.05) ($2.21) ($0.96) ($0.54) ($0.17) $0.01
Weighted Average Basic Shares Outstanding
52.42M 53.03M 71.25M 114.94M 117.39M 120.39M 122.67M
Diluted Earnings per Share
($1.10) ($1.05) ($2.21) ($0.96) ($0.54) ($0.17) $0.01
Weighted Average Diluted Shares Outstanding
52.42M 53.03M 71.25M 114.94M 117.39M 120.39M 125.10M
Weighted Average Basic & Diluted Shares Outstanding
- - 114.93M 115.96M 118.16M 120.86M 122.45M

Quarterly Income Statements for Warby Parker

This table shows Warby Parker's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-18 -18 -2.77 -6.78 -4.10 -6.74 3.48 -1.58 5.97 -6.23 2.85
Consolidated Net Income / (Loss)
-17 -19 -2.68 -6.76 -4.07 -6.88 3.47 -1.75 5.87 -5.95 3.18
Net Income / (Loss) Continuing Operations
-17 -19 -2.68 -6.76 -4.07 -6.88 3.47 -1.75 5.87 -5.95 3.18
Total Pre-Tax Income
-17 -19 -2.57 -6.39 -3.77 -6.78 4.93 -2.54 5.75 -5.09 4.00
Total Operating Income
-20 -22 -5.13 -8.96 -6.61 -9.42 2.47 -4.53 3.57 -6.85 1.67
Total Gross Profit
93 87 113 105 105 103 126 114 120 111 131
Total Revenue
170 162 200 188 192 191 224 214 222 212 242
Operating Revenue
170 162 200 188 192 191 224 214 222 212 242
Total Cost of Revenue
77 75 87 83 88 88 98 101 102 101 111
Operating Cost of Revenue
77 75 87 83 88 88 98 101 102 101 111
Total Operating Expenses
112 109 119 114 111 113 124 118 116 118 129
Selling, General & Admin Expense
112 109 119 114 111 113 124 118 116 118 129
Total Other Income / (Expense), net
2.66 2.42 2.56 2.57 2.84 2.63 2.46 1.98 2.18 1.76 2.33
Other Income / (Expense), net
2.66 2.42 2.56 2.57 2.84 2.63 2.46 1.98 2.18 1.76 2.33
Income Tax Expense
0.30 -0.11 0.11 0.37 0.30 0.09 1.45 -0.79 -0.13 0.86 0.82
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)
0.27 - 0.09 0.02 0.03 - -0.01 -0.17 -0.10 - 0.33
Basic Earnings per Share
($0.15) ($0.16) ($0.02) ($0.06) ($0.03) ($0.06) $0.03 ($0.01) $0.05 ($0.06) $0.03
Weighted Average Basic Shares Outstanding
118.00M 117.39M 119.14M 120.09M 120.89M 120.39M 121.95M 122.57M 122.96M 122.67M 123.44M
Diluted Earnings per Share
($0.15) ($0.16) ($0.02) ($0.06) ($0.03) ($0.06) $0.03 ($0.01) $0.05 ($0.06) $0.03
Weighted Average Diluted Shares Outstanding
118.00M 117.39M 119.14M 120.09M 120.89M 120.39M 124.63M 122.57M 125.41M 125.10M 125.55M
Weighted Average Basic & Diluted Shares Outstanding
117.64M 118.16M 118.86M 119.84M 120.34M 120.86M 121.41M 121.96M 122.16M 122.45M 122.72M

Annual Cash Flow Statements for Warby Parker

This table details how cash moves in and out of Warby Parker's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-94 259 -58 -48 8.31 37 32
Net Cash From Operating Activities
21 33 -32 10 61 99 111
Net Cash From Continuing Operating Activities
21 33 -32 10 61 99 111
Net Income / (Loss) Continuing Operations
0.00 -56 -144 -110 -63 -20 1.64
Consolidated Net Income / (Loss)
0.00 -56 -144 -110 -63 -20 1.64
Depreciation Expense
15 18 22 32 39 46 50
Amortization Expense
- - 0.00 0.25 2.90 3.70 3.41
Non-Cash Adjustments To Reconcile Net Income
8.50 46 115 103 77 50 38
Changes in Operating Assets and Liabilities, net
-1.62 25 -24 -15 5.81 19 18
Net Cash From Investing Activities
-33 -20 -49 -60 -55 -66 -67
Net Cash From Continuing Investing Activities
-33 -20 -49 -60 -55 -66 -67
Purchase of Property, Plant & Equipment
-33 -20 -49 -60 -54 -64 -67
Purchase of Investments
- - 0.00 0.00 -1.00 -2.00 0.00
Net Cash From Financing Activities
-83 246 23 3.29 2.87 4.96 -12
Net Cash From Continuing Financing Activities
-83 2.28 23 3.29 2.87 4.96 -12
Issuance of Debt
0.00 31 - - - - 0.03
Issuance of Common Equity
0.30 1.33 20 3.20 2.87 4.63 2.36
Other Financing Activities, net
-4.78 0.00 -21 - 0.00 0.00 -14
Effect of Exchange Rate Changes
- 0.04 -0.16 -1.31 -0.88 -0.40 0.46
Cash Interest Paid
0.09 0.47 0.15 0.18 0.23 0.25 0.33
Cash Income Taxes Paid
0.37 0.23 0.36 0.54 0.42 1.04 0.78

Quarterly Cash Flow Statements for Warby Parker

This table details how cash moves in and out of Warby Parker's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
3.31 0.93 3.49 18 13 3.13 7.44 21 -6.02 6.00 -1.70
Net Cash From Operating Activities
20 14 20 32 27 20 29 40 18 23 25
Net Cash From Continuing Operating Activities
20 14 20 32 27 20 26 40 18 23 21
Net Income / (Loss) Continuing Operations
-17 -19 -2.68 -6.76 -4.07 -6.88 3.47 -1.75 5.87 -5.95 3.18
Consolidated Net Income / (Loss)
-17 -19 -2.68 -6.76 -4.07 -6.88 3.47 -1.75 5.87 -5.95 3.18
Depreciation Expense
9.76 10 11 11 12 12 8.70 12 13 13 9.86
Amortization Expense
0.85 1.22 1.07 0.94 0.85 0.84 0.74 0.75 0.90 1.01 1.02
Non-Cash Adjustments To Reconcile Net Income
20 18 14 16 11 8.92 13 12 7.06 6.32 12
Changes in Operating Assets and Liabilities, net
7.09 2.88 -3.50 10 7.79 4.69 0.34 17 -8.39 8.77 -5.32
Net Cash From Investing Activities
-16 -14 -16 -18 -14 -18 -16 -16 -19 -15 -16
Net Cash From Continuing Investing Activities
-16 -14 -16 -18 -14 -18 -16 -16 -19 -15 -16
Purchase of Property, Plant & Equipment
-15 -14 -14 -18 -14 -18 -16 -16 -19 -15 -16
Net Cash From Financing Activities
0.17 0.73 0.09 3.62 0.05 1.21 -2.30 -2.77 -4.61 -2.31 -6.16
Net Cash From Continuing Financing Activities
0.17 0.73 0.09 3.62 0.05 1.21 -2.30 -2.77 -4.61 -2.31 -6.16
Issuance of Common Equity
0.17 0.73 0.09 3.62 0.05 0.87 0.04 1.25 0.03 1.05 0.00
Other Financing Activities, net
- - 0.00 - - - -2.34 -4.02 -4.64 -3.39 -6.16
Cash Interest Paid
0.05 0.07 0.08 0.02 0.08 0.08 0.10 0.07 0.07 0.08 0.08
Cash Income Taxes Paid
0.07 0.02 0.07 0.28 0.44 0.25 0.04 0.61 0.07 0.07 0.22

Annual Balance Sheets for Warby Parker

This table presents Warby Parker's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
445 441 569 580 676 721
Total Current Assets
360 328 295 299 326 352
Cash & Equivalents
314 256 209 217 254 286
Accounts Receivable
0.60 0.99 1.44 1.78 1.95 3.29
Inventories, net
38 57 69 62 52 45
Prepaid Expenses
6.78 13 16 18 18 18
Plant, Property, & Equipment, net
85 112 139 152 170 187
Total Noncurrent Assets
0.28 0.47 136 129 180 181
Other Noncurrent Operating Assets
0.28 0.47 136 129 180 181
Total Liabilities & Shareholders' Equity
445 441 569 580 676 721
Total Liabilities
136 155 282 279 336 353
Total Current Liabilities
105 118 130 127 130 150
Accounts Payable
41 31 21 22 24 32
Accrued Expenses
34 61 58 46 52 49
Current Deferred Revenue
27 22 26 32 32 34
Other Current Liabilities
3.72 4.30 25 27 23 35
Total Noncurrent Liabilities
31 37 153 151 206 203
Other Noncurrent Operating Liabilities
3.01 0.00 153 151 206 203
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-198 286 287 302 340 368
Total Preferred & Common Equity
-198 286 287 302 340 368
Total Common Equity
-198 286 287 302 340 368
Common Stock
127 779 891 970 1,029 1,055
Retained Earnings
-325 -493 -604 -667 -687 -686
Accumulated Other Comprehensive Income / (Loss)
0.11 0.02 -0.65 -1.53 -1.94 -1.48

Quarterly Balance Sheets for Warby Parker

This table presents Warby Parker's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
550 558 562 575 593 618 638 683 702 707 736
Total Current Assets
282 285 288 295 296 309 321 331 346 344 358
Cash & Equivalents
198 204 213 216 220 238 251 265 286 280 288
Accounts Receivable
1.11 0.96 1.18 0.72 1.17 1.21 1.09 1.47 1.14 1.14 1.76
Inventories, net
71 64 60 64 56 53 53 49 43 46 46
Prepaid Expenses
13 15 14 15 18 16 16 15 15 17 21
Plant, Property, & Equipment, net
134 140 144 151 157 163 167 174 177 183 191
Total Noncurrent Assets
134 133 130 128 140 147 150 178 179 180 187
Other Noncurrent Operating Assets
134 133 130 128 140 147 150 178 179 180 187
Total Liabilities & Shareholders' Equity
550 558 562 575 593 618 638 683 702 707 736
Total Liabilities
266 262 260 270 277 289 301 329 340 337 361
Total Current Liabilities
111 111 110 122 119 121 130 123 136 132 153
Accounts Payable
20 20 24 24 27 25 37 27 26 11 37
Accrued Expenses
53 48 43 55 43 48 46 52 61 68 60
Current Deferred Revenue
16 19 19 18 21 21 19 23 22 22 21
Other Current Liabilities
22 24 25 25 27 28 28 22 27 32 35
Total Noncurrent Liabilities
155 150 149 148 158 168 171 206 205 205 207
Other Noncurrent Operating Liabilities
155 150 149 148 158 168 171 206 205 205 207
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
284 296 302 305 316 329 337 354 361 370 376
Total Preferred & Common Equity
284 296 302 305 316 329 337 354 361 370 376
Total Common Equity
284 296 302 305 316 329 337 354 361 370 376
Common Stock
868 912 934 954 987 1,007 1,019 1,040 1,049 1,051 1,060
Retained Earnings
-583 -614 -630 -648 -670 -676 -680 -684 -686 -680 -682
Accumulated Other Comprehensive Income / (Loss)
-0.42 -1.33 -1.37 -1.64 -1.62 -1.64 -1.67 -1.93 -1.76 -1.66 -1.81

Annual Metrics And Ratios for Warby Parker

This table displays calculated financial ratios and metrics derived from Warby Parker's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - -
Revenue Growth
0.00% 6.28% 37.36% 10.60% 11.98% 15.16% 13.04%
EBITDA Growth
0.00% -356.67% -222.54% 36.48% 72.60% 241.00% 88.75%
EBIT Growth
0.00% -20,291.67% -158.41% 23.69% 42.89% 68.91% 115.59%
NOPAT Growth
0.00% 0.00% -158.23% 22.59% 35.26% 58.18% 86.35%
Net Income Growth
0.00% 0.00% -158.00% 23.48% 42.75% 67.74% 108.05%
EPS Growth
0.00% 4.55% -110.48% 56.56% 43.75% 68.52% 105.88%
Operating Cash Flow Growth
0.00% 53.12% -197.67% 132.41% 488.15% 61.90% 12.19%
Free Cash Flow Firm Growth
0.00% 0.00% -308.22% 6.99% 54.70% 61.39% 107.52%
Invested Capital Growth
0.00% 0.00% 621.54% 163.88% 8.75% 1.20% -5.28%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 2.33% 2.35% 3.88% 2.51%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 26.65% 14.77% 86.69% 4.87%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 18.81% 1.84% 38.79% 125.41%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 17.86% 0.20% 28.75% 31.42%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 18.85% 1.87% 37.38% 128.87%
EPS Q/Q Growth
0.00% 0.00% 0.00% 17.95% 1.82% 37.04% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -266.31% 122.88% -14.30% 6.75% 3.11%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -7.84% 17.11% 121.47%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -9.31% -4.23% 0.23% -8.84%
Profitability Metrics
- - - - - - -
Gross Margin
60.22% 58.91% 58.76% 57.02% 54.53% 55.34% 53.97%
EBITDA Margin
3.99% -9.64% -22.64% -13.01% -3.18% 3.90% 6.51%
Operating Margin
-0.45% -14.13% -26.56% -18.59% -10.75% -3.90% -0.61%
EBIT Margin
0.07% -14.15% -26.63% -18.37% -9.37% -2.53% 0.35%
Profit (Net Income) Margin
0.00% -14.20% -26.68% -18.46% -9.44% -2.64% 0.19%
Tax Burden Percent
0.00% 100.34% 100.18% 100.45% 100.69% 104.48% 53.93%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 46.07%
Return on Invested Capital (ROIC)
0.00% 0.00% -841.18% -144.63% -61.85% -24.68% -3.44%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -825.85% -130.63% -55.84% -24.97% -5.11%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 792.63% 106.07% 40.37% 18.33% 3.90%
Return on Equity (ROE)
0.00% -18.13% -48.54% -38.56% -21.48% -6.35% 0.46%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -459.12% -234.70% -70.24% -25.87% 1.99%
Operating Return on Assets (OROA)
0.00% -12.53% -32.53% -21.78% -10.92% -3.11% 0.44%
Return on Assets (ROA)
0.00% -12.57% -32.59% -21.87% -11.00% -3.24% 0.23%
Return on Common Equity (ROCE)
0.00% 11.65% -7.18% -38.56% -21.48% -6.35% 0.46%
Return on Equity Simple (ROE_SIMPLE)
0.00% 28.23% -50.44% -38.51% -20.94% -6.00% 0.00%
Net Operating Profit after Tax (NOPAT)
0.00 -39 -101 -78 -50 -21 -2.88
NOPAT Margin
0.00% -9.89% -18.60% -13.01% -7.52% -2.73% -0.33%
Net Nonoperating Expense Percent (NNEP)
0.00% -10.81% -15.32% -14.00% -6.02% 0.29% 1.67%
Return On Investment Capital (ROIC_SIMPLE)
- - - -27.16% -16.70% -6.20% -0.78%
Cost of Revenue to Revenue
39.78% 41.09% 41.24% 42.98% 45.47% 44.66% 46.03%
SG&A Expenses to Revenue
60.67% 73.04% 85.32% 75.62% 65.28% 59.24% 54.58%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
60.67% 73.04% 85.32% 75.62% 65.28% 59.24% 54.58%
Earnings before Interest and Taxes (EBIT)
0.28 -56 -144 -110 -63 -20 3.04
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
15 -38 -122 -78 -21 30 57
Valuation Ratios
- - - - - - -
Price to Book Value (P/BV)
0.00 0.00 18.43 5.44 5.50 8.57 7.24
Price to Tangible Book Value (P/TBV)
0.00 0.00 18.43 5.44 5.50 8.57 7.24
Price to Revenue (P/Rev)
8.39 7.90 9.74 2.61 2.48 3.78 3.05
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 1,622.16
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 169.47 17.31 16.98 30.95 29.19
Enterprise Value to Revenue (EV/Rev)
0.00 8.39 9.27 2.26 2.15 3.45 2.72
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 88.48 41.88
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 780.68
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 100.80 0.00 130.30 23.64 26.93 21.44
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 1,428.98
Leverage & Solvency
- - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -1.02 -0.96 -0.81 -0.72 -0.73 -0.76
Leverage Ratio
0.00 1.44 1.49 1.76 1.95 1.96 1.97
Compound Leverage Factor
0.00 1.44 1.49 1.76 1.95 1.96 1.97
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 164.23% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -64.23% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.00 13.82 19.60 2.59 3.12 5.17 4.75
Noncontrolling Interest Sharing Ratio
0.00% 164.23% 85.21% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - -
Current Ratio
0.00 3.42 2.78 2.27 2.35 2.50 2.35
Quick Ratio
0.00 2.99 2.18 1.62 1.72 1.96 1.93
Cash Flow Metrics
- - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -33 -136 -126 -57 -22 1.66
Operating Cash Flow to CapEx
65.56% 163.22% -65.95% 17.23% 113.64% 154.21% 165.23%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - -
Asset Turnover
0.00 0.89 1.22 1.19 1.17 1.23 1.25
Accounts Receivable Turnover
0.00 655.11 678.97 492.88 416.78 413.91 333.23
Inventory Turnover
0.00 4.21 4.67 4.08 4.65 6.01 8.29
Fixed Asset Turnover
0.00 4.66 5.50 4.77 4.60 4.78 4.87
Accounts Payable Turnover
0.00 3.97 6.22 9.95 14.08 14.99 14.46
Days Sales Outstanding (DSO)
0.00 0.56 0.54 0.74 0.88 0.88 1.10
Days Inventory Outstanding (DIO)
0.00 86.79 78.19 89.42 78.55 60.70 44.05
Days Payable Outstanding (DPO)
0.00 92.02 58.65 36.69 25.92 24.36 25.24
Cash Conversion Cycle (CCC)
0.00 -4.68 20.08 53.47 53.51 37.23 19.90
Capital & Investment Metrics
- - - - - - -
Invested Capital
0.00 -5.67 30 78 85 86 81
Invested Capital Turnover
0.00 -138.83 45.24 11.11 8.22 9.03 10.42
Increase / (Decrease) in Invested Capital
0.00 -5.67 35 48 6.83 1.02 -4.54
Enterprise Value (EV)
0.00 3,302 5,013 1,351 1,442 2,659 2,376
Market Capitalization
3,110 3,110 5,270 1,560 1,659 2,913 2,662
Book Value per Share
$0.00 ($3.74) $4.01 $2.48 $2.57 $2.83 $3.01
Tangible Book Value per Share
$0.00 ($3.74) $4.01 $2.48 $2.57 $2.83 $3.01
Total Capital
0.00 308 286 287 302 340 368
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
0.00 -314 -256 -209 -217 -254 -286
Capital Expenditures (CapEx)
33 20 49 60 54 64 67
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -59 -47 -44 -45 -58 -84
Debt-free Net Working Capital (DFNWC)
0.00 255 210 165 172 196 202
Net Working Capital (NWC)
0.00 255 210 165 172 196 202
Net Nonoperating Expense (NNE)
0.00 17 44 33 13 -0.69 -4.52
Net Nonoperating Obligations (NNO)
0.00 -314 -256 -209 -217 -254 -286
Total Depreciation and Amortization (D&A)
15 18 22 32 41 50 54
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -15.11% -8.61% -7.29% -6.77% -7.58% -9.64%
Debt-free Net Working Capital to Revenue
0.00% 64.67% 38.81% 27.59% 25.61% 25.37% 23.20%
Net Working Capital to Revenue
0.00% 64.67% 38.81% 27.59% 25.61% 25.37% 23.20%
Earnings Adjustments
- - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($2.21) ($0.96) ($0.54) ($0.17) $0.01
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 71.25M 114.94M 117.39M 120.39M 122.67M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($2.21) ($0.96) ($0.54) ($0.17) $0.01
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 71.25M 114.94M 117.39M 120.39M 125.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 114.93M 115.96M 118.16M 120.86M 122.45M
Normalized Net Operating Profit after Tax (NOPAT)
-1.16 -39 -101 -78 -50 -21 -2.88
Normalized NOPAT Margin
-0.31% -9.89% -18.60% -13.01% -7.52% -2.73% -0.33%
Pre Tax Income Margin
0.07% -14.15% -26.63% -18.37% -9.37% -2.53% 0.35%
Debt Service Ratios
- - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% -5.60% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Warby Parker

This table displays calculated financial ratios and metrics derived from Warby Parker's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 122,447,777.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 122,447,777.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.02
Growth Metrics
- - - - - - - - - - -
Revenue Growth
14.16% 10.49% 16.30% 13.32% 13.30% 17.79% 11.89% 13.95% 15.19% 11.19% 8.34%
EBITDA Growth
57.85% 32.81% 966.89% 191.37% 237.13% 184.46% 96.20% 88.74% 115.25% 41.22% 3.61%
EBIT Growth
28.27% 5.79% 75.63% 59.94% 77.96% 64.58% 291.60% 60.23% 252.45% 24.96% -18.84%
NOPAT Growth
16.50% 0.65% 58.75% 50.87% 66.55% 56.34% 148.53% 49.48% 178.80% 27.23% -23.94%
Net Income Growth
26.97% 5.95% 75.22% 57.54% 76.62% 63.89% 229.60% 74.09% 244.25% 13.44% -8.50%
EPS Growth
28.57% 5.88% 77.78% 57.14% 80.00% 62.50% 250.00% 83.33% 266.67% 0.00% 0.00%
Operating Cash Flow Growth
1,625.63% -42.68% 130.56% 68.64% 36.88% 45.72% 47.33% 27.12% -34.12% 16.78% -16.51%
Free Cash Flow Firm Growth
78.78% 65.56% 85.45% 73.86% 89.63% 65.30% 216.73% 259.10% 105.92% 96.63% -67.40%
Invested Capital Growth
2.99% 8.75% 4.04% 2.27% -3.30% 1.20% -7.09% -17.90% 4.14% -5.28% -1.64%
Revenue Q/Q Growth
2.26% -4.71% 23.57% -5.89% 2.24% -0.94% 17.38% -4.16% 3.36% -4.38% 14.38%
EBITDA Q/Q Growth
-4.79% -16.42% 220.08% -37.62% 57.26% -28.30% 178.95% -39.99% 79.35% -52.96% 64.86%
EBIT Q/Q Growth
-7.29% -11.92% 86.58% -148.50% 40.98% -79.90% 172.61% -151.58% 326.25% -188.55% 178.53%
NOPAT Q/Q Growth
-8.43% -9.12% 76.23% -74.68% 26.16% -42.39% 126.42% -281.87% 215.16% -231.49% 127.62%
Net Income Q/Q Growth
-9.34% -9.38% 85.93% -152.41% 39.78% -68.89% 150.49% -150.46% 435.27% -201.34% 153.37%
EPS Q/Q Growth
-7.14% -6.67% 87.50% -200.00% 50.00% -100.00% 150.00% -133.33% 600.00% -220.00% 150.00%
Operating Cash Flow Q/Q Growth
6.29% -31.44% 45.83% 58.69% -13.73% -27.01% 47.44% 36.93% -55.29% 29.38% 5.41%
Free Cash Flow Firm Q/Q Growth
48.30% -33.65% 66.68% -13.53% 79.49% -347.37% 212.08% 54.73% -99.24% -354.81% 1,184.51%
Invested Capital Q/Q Growth
-0.85% -4.23% 12.85% -4.56% -6.25% 0.23% 3.61% -15.67% 18.91% -8.84% 7.60%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
54.60% 53.79% 56.73% 55.99% 54.49% 54.09% 56.30% 52.97% 54.11% 52.39% 54.05%
EBITDA Margin
-3.83% -4.67% 4.54% 3.01% 4.63% 3.35% 7.97% 4.99% 8.65% 4.26% 6.14%
Operating Margin
-11.64% -13.33% -2.56% -4.76% -3.44% -4.94% 1.10% -2.11% 1.61% -3.23% 0.69%
EBIT Margin
-10.07% -11.83% -1.29% -3.39% -1.96% -3.56% 2.20% -1.18% 2.59% -2.40% 1.65%
Profit (Net Income) Margin
-10.25% -11.77% -1.34% -3.59% -2.12% -3.61% 1.55% -0.82% 2.65% -2.81% 1.31%
Tax Burden Percent
101.76% 99.45% 104.20% 105.84% 107.98% 101.37% 70.48% 68.95% 102.17% 116.93% 79.46%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 29.52% 0.00% -2.17% 0.00% 20.54%
Return on Invested Capital (ROIC)
-61.03% -76.68% -13.33% -26.52% -20.49% -31.23% 6.70% -14.57% 16.00% -23.59% 5.51%
ROIC Less NNEP Spread (ROIC-NNEP)
-59.30% -74.83% -13.76% -26.30% -20.73% -31.10% 5.98% -15.11% 15.16% -23.16% 4.84%
Return on Net Nonoperating Assets (RNNOA)
41.69% 54.10% 9.54% 18.77% 15.09% 22.83% -4.33% 11.47% -11.40% 17.69% -3.67%
Return on Equity (ROE)
-19.33% -22.58% -3.79% -7.75% -5.40% -8.40% 2.36% -3.10% 4.59% -5.90% 1.84%
Cash Return on Invested Capital (CROIC)
-60.75% -70.24% -52.16% -45.14% -30.58% -25.87% -9.71% 4.45% -8.85% 1.99% -2.78%
Operating Return on Assets (OROA)
-11.72% -13.79% -1.56% -4.14% -2.40% -4.37% 2.74% -1.47% 3.28% -3.00% 2.07%
Return on Assets (ROA)
-11.93% -13.72% -1.62% -4.38% -2.59% -4.43% 1.93% -1.02% 3.35% -3.50% 1.64%
Return on Common Equity (ROCE)
-19.33% -22.58% -3.79% -7.75% -5.40% -8.40% 2.36% -3.10% 4.59% -5.90% 1.84%
Return on Equity Simple (ROE_SIMPLE)
-21.14% 0.00% -17.42% -13.94% -9.67% 0.00% -4.02% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-14 -15 -3.59 -6.27 -4.63 -6.59 1.74 -3.17 3.65 -4.80 1.32
NOPAT Margin
-8.15% -9.33% -1.79% -3.33% -2.41% -3.46% 0.78% -1.48% 1.65% -2.26% 0.55%
Net Nonoperating Expense Percent (NNEP)
-1.73% -1.86% 0.43% -0.22% 0.24% -0.12% 0.71% 0.54% 0.84% -0.43% 0.67%
Return On Investment Capital (ROIC_SIMPLE)
- -5.00% - - - -1.94% 0.49% -0.88% 0.99% -1.30% 0.35%
Cost of Revenue to Revenue
45.40% 46.21% 43.27% 44.01% 45.51% 45.91% 43.70% 47.03% 45.89% 47.61% 45.95%
SG&A Expenses to Revenue
66.23% 67.12% 59.29% 60.75% 57.93% 59.03% 55.19% 55.08% 52.50% 55.62% 53.36%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
66.23% 67.12% 59.29% 60.75% 57.93% 59.03% 55.19% 55.08% 52.50% 55.62% 53.36%
Earnings before Interest and Taxes (EBIT)
-17 -19 -2.57 -6.39 -3.77 -6.78 4.93 -2.54 5.75 -5.09 4.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-6.50 -7.57 9.09 5.67 8.91 6.39 18 11 19 9.02 15
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.06 5.50 5.09 5.80 5.81 8.57 6.22 7.37 9.10 7.24 6.87
Price to Tangible Book Value (P/TBV)
5.06 5.50 5.09 5.80 5.81 8.57 6.22 7.37 9.10 7.24 6.87
Price to Revenue (P/Rev)
2.35 2.48 2.30 2.65 2.64 3.78 2.77 3.24 3.95 3.05 2.90
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2,960.93 1,622.16 2,549.38
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.03% 0.06% 0.04%
Enterprise Value to Invested Capital (EV/IC)
14.95 16.98 14.49 18.28 19.90 30.95 21.77 31.65 34.54 29.19 26.17
Enterprise Value to Revenue (EV/Rev)
2.02 2.15 1.99 2.32 2.30 3.45 2.44 2.89 3.62 2.72 2.57
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 2,432.27 105.97 88.48 49.96 54.22 57.00 41.88 40.03
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2,283.89 780.68 1,083.56
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
18.62 23.64 19.20 19.62 18.44 26.93 17.92 20.35 28.70 21.44 21.63
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 640.98 0.00 1,428.98 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.70 -0.72 -0.69 -0.71 -0.73 -0.73 -0.72 -0.76 -0.75 -0.76 -0.76
Leverage Ratio
1.91 1.95 1.88 1.87 1.89 1.96 1.90 1.91 1.90 1.97 1.94
Compound Leverage Factor
1.91 1.95 1.88 1.87 1.89 1.96 1.90 1.91 1.90 1.97 1.94
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
3.25 3.36 3.43 3.93 3.91 5.23 4.17 4.84 6.23 4.71 4.56
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.43 2.35 2.50 2.55 2.47 2.50 2.70 2.55 2.61 2.35 2.33
Quick Ratio
1.78 1.72 1.87 1.98 1.94 1.96 2.17 2.12 2.13 1.93 1.89
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-16 -22 -7.31 -8.30 -1.70 -7.61 8.53 13 0.10 -0.26 2.78
Operating Cash Flow to CapEx
128.69% 100.68% 138.03% 179.16% 191.82% 112.36% 181.76% 246.83% 92.22% 153.80% 151.88%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.16 1.17 1.21 1.22 1.22 1.23 1.25 1.24 1.26 1.25 1.26
Accounts Receivable Turnover
715.19 416.78 655.52 603.46 818.21 413.91 602.34 699.61 760.46 333.23 550.75
Inventory Turnover
4.41 4.65 5.19 5.68 5.70 6.01 6.77 7.74 7.89 8.29 8.73
Fixed Asset Turnover
4.59 4.60 4.70 4.70 4.68 4.78 4.81 4.83 4.87 4.87 4.88
Accounts Payable Turnover
13.31 14.08 13.46 13.26 10.90 14.99 13.36 14.74 16.32 14.46 13.02
Days Sales Outstanding (DSO)
0.51 0.88 0.56 0.60 0.45 0.88 0.61 0.52 0.48 1.10 0.66
Days Inventory Outstanding (DIO)
82.85 78.55 70.27 64.29 64.02 60.70 53.90 47.17 46.27 44.05 41.81
Days Payable Outstanding (DPO)
27.43 25.92 27.13 27.52 33.49 24.36 27.32 24.77 22.37 25.24 28.04
Cash Conversion Cycle (CCC)
55.93 53.51 43.70 37.37 30.98 37.23 27.19 22.93 24.38 19.90 14.43
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
89 85 96 91 86 86 89 75 89 81 88
Invested Capital Turnover
7.49 8.22 7.43 7.96 8.52 9.03 8.60 9.87 9.72 10.42 10.09
Increase / (Decrease) in Invested Capital
2.57 6.83 3.72 2.03 -2.93 1.02 -6.79 -16 3.55 -4.54 -1.46
Enterprise Value (EV)
1,325 1,442 1,388 1,671 1,706 2,659 1,938 2,376 3,083 2,376 2,292
Market Capitalization
1,541 1,659 1,608 1,909 1,957 2,913 2,203 2,662 3,364 2,662 2,580
Book Value per Share
$2.60 $2.57 $2.68 $2.77 $2.81 $2.83 $2.93 $2.98 $3.03 $3.01 $3.07
Tangible Book Value per Share
$2.60 $2.57 $2.68 $2.77 $2.81 $2.83 $2.93 $2.98 $3.03 $3.01 $3.07
Total Capital
305 302 316 329 337 340 354 361 370 368 376
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-216 -217 -220 -238 -251 -254 -265 -286 -280 -286 -288
Capital Expenditures (CapEx)
15 14 14 18 14 18 16 16 19 15 16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-42 -45 -43 -50 -60 -58 -57 -76 -68 -84 -84
Debt-free Net Working Capital (DFNWC)
174 172 178 188 191 196 208 211 212 202 204
Net Working Capital (NWC)
174 172 178 188 191 196 208 211 212 202 204
Net Nonoperating Expense (NNE)
3.58 3.95 -0.91 0.49 -0.56 0.29 -1.73 -1.42 -2.23 1.16 -1.85
Net Nonoperating Obligations (NNO)
-216 -217 -220 -238 -251 -254 -265 -286 -280 -286 -288
Total Depreciation and Amortization (D&A)
11 12 12 12 13 13 13 13 13 14 11
Debt-free, Cash-free Net Working Capital to Revenue
-6.46% -6.77% -6.13% -6.99% -8.07% -7.58% -7.18% -9.23% -8.04% -9.64% -9.41%
Debt-free Net Working Capital to Revenue
26.54% 25.61% 25.45% 26.06% 25.74% 25.37% 26.16% 25.64% 24.92% 23.20% 22.95%
Net Working Capital to Revenue
26.54% 25.61% 25.45% 26.06% 25.74% 25.37% 26.16% 25.64% 24.92% 23.20% 22.95%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.15) ($0.16) ($0.02) ($0.06) ($0.03) ($0.06) $0.03 ($0.01) $0.05 ($0.06) $0.03
Adjusted Weighted Average Basic Shares Outstanding
118.00M 117.39M 119.14M 120.09M 120.89M 120.39M 121.95M 122.57M 122.96M 122.67M 123.44M
Adjusted Diluted Earnings per Share
($0.15) ($0.16) ($0.02) ($0.06) ($0.03) ($0.06) $0.03 ($0.01) $0.05 ($0.06) $0.03
Adjusted Weighted Average Diluted Shares Outstanding
118.00M 117.39M 119.14M 120.09M 120.89M 120.39M 124.63M 122.57M 125.41M 125.10M 125.55M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
117.64M 118.16M 118.86M 119.84M 120.34M 120.86M 121.41M 121.96M 122.16M 122.45M 122.72M
Normalized Net Operating Profit after Tax (NOPAT)
-14 -15 -3.59 -6.27 -4.63 -6.59 1.74 -3.17 2.50 -4.80 1.32
Normalized NOPAT Margin
-8.15% -9.33% -1.79% -3.33% -2.41% -3.46% 0.78% -1.48% 1.13% -2.26% 0.55%
Pre Tax Income Margin
-10.07% -11.83% -1.29% -3.39% -1.96% -3.56% 2.20% -1.18% 2.59% -2.40% 1.65%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise four-year trend snapshot for Warby Parker (WRBY), focusing on the quarterly statements from 2022 through 2025. The data show top-line growth and improving cash generation, but profitability remains uneven across quarters.

  • Top-line growth: Total revenue rose to about $211.97 million in Q4 2025, up from about $146.49 million in Q4 2022, indicating steady revenue expansion over the period.
  • Ongoing positive operating cash flow: Net cash from continuing operating activities was positive in every quarter of 2025, with Q1 2025 at $29.36M, Q2 2025 at $31.62M, Q3 2025 at $17.97M, and Q4 2025 at $23.25M, signaling improving cash generation.
  • Liquidity improvement: Cash & equivalents stood at about $280.36 million as of Q3 2025, providing a healthy liquidity buffer.
  • Stable gross margins: Gross margin has typically been in the mid-50% range (roughly 52–54%), indicating consistent profitability per dollar of revenue across the period.
  • Partial profitability signal: In Q3 2025, net income and diluted earnings per share turned positive (net income around $5.87M; diluted EPS about $0.05), suggesting a potential narrowing of losses in some quarters.
  • Debt profile: There is no explicit long-term debt shown in the provided data, suggesting a relatively debt-light or debt-free balance sheet within the periods reviewed.
  • Equity base: Total common equity hovered in the mid to upper hundreds of millions (e.g., around $336.8M–$369.6M in 2024–2025), indicating a solid and somewhat growing equity base over time.
  • Capital expenditures: Capex remains moderate, with purchases of property, plant & equipment typically in the $15–20 million per quarter range, signaling ongoing reinvestment in stores and infrastructure.
  • Profitability challenge in some periods: Net income attributable to common shareholders was negative in Q4 2025 (about -$6.23 million), highlighting continued quarterly profitability challenges despite improving cash flow and top-line growth.
  • Expense pressure: Selling, General & Admin (SG&A) expenses remained a significant expense line (e.g., about $117.9 million in Q4 2025), contributing to operating losses in certain quarters despite revenue gains.
05/14/26 02:32 PM ETAI Generated. May Contain Errors.

Warby Parker Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Warby Parker's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Warby Parker's net income appears to be on a downward trend, with a most recent value of $1.64 million in 2025, rising from $0.00 in 2019. The previous period was -$20.39 million in 2024. Check out Warby Parker's forecast to explore projected trends and price targets.

Warby Parker's total operating income in 2025 was -$5.34 million, based on the following breakdown:
  • Total Gross Profit: $470.58 million
  • Total Operating Expenses: $475.92 million

Over the last 6 years, Warby Parker's total revenue changed from $370.46 million in 2019 to $871.91 million in 2025, a change of 135.4%.

Warby Parker's total liabilities were at $353.19 million at the end of 2025, a 5.0% increase from 2024, and a 159.1% increase since 2020.

In the past 5 years, Warby Parker's cash and equivalents has ranged from $208.59 million in 2022 to $314.09 million in 2020, and is currently $286.36 million as of their latest financial filing in 2025.

Over the last 6 years, Warby Parker's book value per share changed from 0.00 in 2019 to 3.01 in 2025, a change of 301.0%.



Financial statements for NYSE:WRBY last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners